Novo’s Outlook for the Year Improves as Drugmaker Weathers Covid

Bookmark
(Bloomberg) -- Novo Nordisk A/S raised its outlook for full-year sales and profit as the Danish drugmaker weathers disruption from Covid-19 and experiences better-than-expected demand for its diabe...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.